Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 264

Sort by

Sort Order Select

Journal Articles

High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels

Blood (2019) 134 (Supplement_1): 666.

https://doi.org/10.1182/blood-2019-127127

Published: 2019

Journal Articles

BCR-ABL1 p190 in CML: A Minor Breakpoint with a Major Impact

Shady Adnan Awad, MD, Helena Hohtari, MD, Komal Kumar Javarappa, PhD, Tania Brandstoetter, Daehong Kim, Swapnil Potdar, MSc, Caroline A Heckman, PhD, Soili Kytölä, PhD, Kimmo Porkka, Eszter Doma, PhD, Veronika Sexl, MD PhD, Matti Kankainen, PhD, Satu Mustjoki, MD PhD

Blood (2019) 134 (Supplement_1): 190.

https://doi.org/10.1182/blood-2019-126584

Published: 2019

Journal Articles

Clinical Significance of Additional Cytogenetic Abnormalities (ACA) at Disease Progression in Patients with High-Risk Myelodysplastic Syndrome (MDS) Treated with Azacitidine

Chiaki Naito, MD, Hiroaki Shimizu, MD PhD, Yuri Miyazawa, MD PhD, Takuma Ishizaki, MD PhD, Akihiko Yokohama, MD PhD, Takayuki Saito, MD PhDProf, Norifumi Tsukamoto, MD PhD, Hiroshi Handa, MD PhD

Blood (2019) 134 (Supplement_1): 5434.

https://doi.org/10.1182/blood-2019-127956

Published: 2019

Journal Articles

Comparison of the Serum Metabolic Signatures Based on 1 H NMR between Thrombotic Antiphospholipid Syndrome (APS) Patients and Healthy Individuals

Melissa Quintero, PhD, Silmara Aparecida De Lima Montalvão, PhD, Ljubica Tasic, PhD, Stephany Cares Huber, PhD, Joyce Maria Annichino- Bizzacchi, MD PhD

Blood (2019) 134 (Supplement_1): 5769.

https://doi.org/10.1182/blood-2019-131927

Published: 2019

Journal Articles

Transcranial Doppler Screening in Children with Sickle Cell Anemia Is Feasible in Central India and Reveals High Risk of Stroke

Dipty Jain, MD, Kavitha Ganesan, MBBS, Sati Sahota, Deepika S. Darbari, MD, Lakshmanan Krishnamurti, MD, Fenella Jane Kirkham, MD

Blood (2019) 134 (Supplement_1): 2279.

https://doi.org/10.1182/blood-2019-131416

Published: 2019

Journal Articles

Stenosis Outcome at 1 and 3 Years after Transplantation Vs Standard-Care in Children with Sickle-Cell Anemia and Abnormal Transcranial Doppler with Stroke or No-Stroke History

Blood (2019) 134 (Supplement_1): 2271.

https://doi.org/10.1182/blood-2019-122699

Published: 2019

Journal Articles

Thrombophilia Testing in Hospitalized Patients with Acute Ischemic Stroke: An Opportunity for Hematology Input

Jori May, MD, Chen Lin, MD, Kimberly Martin, PhD, Laura J Taylor, M.T., Radhika Gangaraju, MD

Blood (2019) 134 (Supplement_1): 2105.

https://doi.org/10.1182/blood-2019-122615

Published: 2019

Journal Articles

Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database

Jonathan C. Roberts, Lynn M Malec, MD, Imrran Halari, Sarah Hale, Abiola Oladapo, Robert Sidonio

Blood (2019) 134 (Supplement_1): 2117.

https://doi.org/10.1182/blood-2019-122164

Published: 2019

Journal Articles

Chronic Myeloid Leukemia Italian Multicenter Observational Study (CML-IT-MOS): Clinical Characteristics of Chronic Myeloid Leukemia (CML) Patients Treated in Real-Life between 2012 and 2016 in 66 Italian Hematology Centers of the Gimema Study Group

Blood (2018) 132 (Supplement 1): 45.

https://doi.org/10.1182/blood-2018-99-116648

Published: 2018

Journal Articles

Development of a Neural Network to Predict Thrombosis in the Antiphospholipid Syndrome with an Accuracy of 87%

Romy Kremers, PhD, Stéphane Zuily, MD PhD, Philip De Groot, PhD, Coenraad Hemker, MD PhD, Denis Wahl, MD PhD, Bas De Laat, MD, PhD

Blood (2018) 132 (Supplement 1): 3796.

https://doi.org/10.1182/blood-2018-99-115834

Published: 2018

Journal Articles

A Long-Term Retrospective Analysis of Arsenic-Containing Triple-Agents Treatment for Acute Promyelocytic Leukemia (APL) in a Cohort from a Single Hospital

Xian Zhang, PhD, Junfang Yang, MD, Fanyong LV, Gailing Zhang, MD, Yunchao Su, MD, Peihua Lu

Blood (2018) 132 (Supplement 1): 4060.

https://doi.org/10.1182/blood-2018-99-117795

Published: 2018

Journal Articles

Venous Thromboembolism in Children 0-18 Years — a Regional Population-Based Study from Sweden

Bader Allahyani, MD, Rolf Ljung, MD PhD Professor

Blood (2018) 132 (Supplement 1): 3805.

https://doi.org/10.1182/blood-2018-99-113844

Published: 2018

Journal Articles

CP-CML Seems Related to Specific HLA Subtypes and the HLA DRB1 07 Allele Might Identify a Subgroup of Newly Diagnosed CP-CML Patients on Imatinib First-Line of Better Prognosis

Franck-Emmanuel Nicolini, MD PhD, Stéphanie Désilets, MD, Sandrine Hayette, PhD, Isabelle Tigaud, MD, Liliana Vila, Stephane Morisset, Stat, Mohamad Sobh, PharmD, Mauricette Michallet, MD PhD, Valerie Dubois, MD

Blood (2018) 132 (Supplement 1): 5436.

https://doi.org/10.1182/blood-2018-99-117733

Published: 2018

Journal Articles

Compound Homozygous Factor V Leiden and Heterozygous Prothrombin Gene Mutation: The First Report in a Pregnant African with Extensive Thrombosis

Livingstone Gayus Dogara, MBBS, FMCPath, Joseph Ogirima Ovosi, MBBS, MSc, FMCP (Clinical Pharmacology), Caleb Mohammed, MBBS, FWACS, Bilkisu Farouk, MBBS, FWACS, Ziphozonke Mafika, MBBCH, MMed, FCPath, Johnny Mahlangu

Blood (2018) 132 (Supplement 1): 5056.

https://doi.org/10.1182/blood-2018-99-114865

Published: 2018

Journal Articles

Kinetic Catalytic Inhibition and Cell-Based Analysis, Not Just Target Binding, Are Required to Assess Kinase Selectivity of Covalent Inhibitors: Comparable BTK vs TEC Selectivity Profile for Ibrutinib and Acalabrutinib

Melissa Hopper, MS, Tarikere Gururaja, PhD, Taisei Kinoshita, PhD, James P. Dean, Ronald Hill, PhD, Ann Mongan, PhD

Blood (2018) 132 (Supplement 1): 3498.

https://doi.org/10.1182/blood-2018-99-110849

Published: 2018

Journal Articles

A Small Nucleolar RNA Linked to Diamond-Blackfan Anemia

Adeline Mayeux, Nathalie Montel-Lehry, Manon Saby, Aurore Anton, Narjesse Karboul, Julie Galimand, Helene Bourdeau, Jonathan Levy, Anne-claude Tabet, Mohandas Narla, DSc, Alyson W. MacInnes, Pascale Dufourcq, Patrick Blader, Thierry Leblanc, Marie-francoise O' Donohue, Pierre-Emmanuel Gleizes, Lydie Da Costa

Blood (2018) 132 (Supplement 1): 1299.

https://doi.org/10.1182/blood-2018-99-110663

Published: 2018

Journal Articles

Deep Molecular Response in Imatinib First-Line 418 Newly Diagnosed CP CML Patients.

Franck Emmanuel Nicolini, MD PhD, Vincent Alcazer, MD, Pascale Cony-Makhoul, MD PhD, Stephanie Dulucq, PhD, Sandrine Hayette, PhD, Isabelle Tigaud, MD, Liliana Villa, MD, Mohamad Sobh, PharmD, Stephane Morisset, Stat, Francois-Xavier Mahon, MD PhD, Gabriel Etienne, MD PhD

Blood (2018) 132 (Supplement 1): 3014.

https://doi.org/10.1182/blood-2018-99-113044

Published: 2018

Journal Articles

Clinical Course of Primary Immune Thrombocytopenia with Positive Antiphospholipid Antibodies

Ana Clara Cruz, Sabrina Saraiva, Marina Pereira Colella, MD, Gabriela G Yamaguti Hayakawa, MD, Erich Vinicius De Paula, MD PhD, Joyce Maria Annichino Bizzacchi, MD PhD, Fernanda Andrade Orsi, MD

Blood (2018) 132 (Supplement 1): 1159.

https://doi.org/10.1182/blood-2018-99-110170

Published: 2018

Journal Articles

Do Current Antiphospholipid Antibody Syndrome Guidelines Effectively Target at-Risk Obstetric Patients?

Kanika Thapar, BA, Nimesh Patel, BS, Bolanle Gbadamosi, MD, Daniel E Ezekwudo, MD, Ishmael Jaiyesimi, DO, MS, Marc Smith, MD

Blood (2018) 132 (Supplement 1): 1208.

https://doi.org/10.1182/blood-2018-99-119380

Published: 2018

Journal Articles

First-Line Second Generation Tyrosine Kinase Inhibitors in Newly Diagnosed Accelerated Phase Chronic Myeloid Leukemia Patients.

Blood (2018) 132 (Supplement 1): 48.

https://doi.org/10.1182/blood-2018-99-113058

Published: 2018

NARROW

High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels

BCR-ABL1 p190 in CML: A Minor Breakpoint with a Major Impact

Clinical Significance of Additional Cytogenetic Abnormalities (ACA) at Disease Progression in Patients with High-Risk Myelodysplastic Syndrome (MDS) Treated with Azacitidine

Comparison of the Serum Metabolic Signatures Based on 1 H NMR between Thrombotic Antiphospholipid Syndrome (APS) Patients and Healthy Individuals

Transcranial Doppler Screening in Children with Sickle Cell Anemia Is Feasible in Central India and Reveals High Risk of Stroke

Stenosis Outcome at 1 and 3 Years after Transplantation Vs Standard-Care in Children with Sickle-Cell Anemia and Abnormal Transcranial Doppler with Stroke or No-Stroke History

Thrombophilia Testing in Hospitalized Patients with Acute Ischemic Stroke: An Opportunity for Hematology Input

Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database

Chronic Myeloid Leukemia Italian Multicenter Observational Study (CML-IT-MOS): Clinical Characteristics of Chronic Myeloid Leukemia (CML) Patients Treated in Real-Life between 2012 and 2016 in 66 Italian Hematology Centers of the Gimema Study Group

Development of a Neural Network to Predict Thrombosis in the Antiphospholipid Syndrome with an Accuracy of 87%

A Long-Term Retrospective Analysis of Arsenic-Containing Triple-Agents Treatment for Acute Promyelocytic Leukemia (APL) in a Cohort from a Single Hospital

Venous Thromboembolism in Children 0-18 Years — a Regional Population-Based Study from Sweden

CP-CML Seems Related to Specific HLA Subtypes and the HLA DRB1 07 Allele Might Identify a Subgroup of Newly Diagnosed CP-CML Patients on Imatinib First-Line of Better Prognosis

Compound Homozygous Factor V Leiden and Heterozygous Prothrombin Gene Mutation: The First Report in a Pregnant African with Extensive Thrombosis

Kinetic Catalytic Inhibition and Cell-Based Analysis, Not Just Target Binding, Are Required to Assess Kinase Selectivity of Covalent Inhibitors: Comparable BTK vs TEC Selectivity Profile for Ibrutinib and Acalabrutinib

A Small Nucleolar RNA Linked to Diamond-Blackfan Anemia

Deep Molecular Response in Imatinib First-Line 418 Newly Diagnosed CP CML Patients.

Clinical Course of Primary Immune Thrombocytopenia with Positive Antiphospholipid Antibodies

Do Current Antiphospholipid Antibody Syndrome Guidelines Effectively Target at-Risk Obstetric Patients?

First-Line Second Generation Tyrosine Kinase Inhibitors in Newly Diagnosed Accelerated Phase Chronic Myeloid Leukemia Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only